Eldelumab (Anti-CXCL10 / IP-10)
Eldelumab (Anti-CXCL10 / IP-10) is a humanised monoclonal antibody (IgG1 type) targeting CXCL10. Eldelumab selectively binds to CXCL10 and blocks CXCL10-induced calcium flux and cell migration. Eldelumab can be used in studies of autoimmune and auto-inflammatory diseases such as rheumatoid arthritis, ulcerative colitis and crohn's disease. MW: 145.5 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2525 |
Sku # | A2525-1mg*5 |
Pricing | 1mg*5, $1970.00 |